Literature DB >> 16513735

Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates.

Gary P Richards1, Alberto Nuñez.   

Abstract

Recently, phosphoglucose isomerase with a lysyl aminopeptidase (PGI-LysAP) activity was identified in Vibrio vulnificus. In this paper, we demonstrate the proteolytic cleavage of human-derived peptides by PGI-LysAP of V. vulnificus using three approaches: (i) a quantitative fluorescent ninhydrin assay for free lysine, (ii) matrix-assisted laser desorption ionization-two-stage time of flight mass spectrometry (MALDI-TOF-TOF), and (iii) Tricine gel electrophoresis. PGI-LysAP hydrolyzed bradykinin, Lys-bradykinin, Lys-(des-Arg9)-bradykinin, neurokinin A, Met-Lys-bradykinin, histatin 8, and a myosin light chain fragment. We detected the proteolytic release of free L-lysine from peptide digests using a rapid, simple, sensitive, and quantitative fluorescent ninhydrin assay, and results were confirmed by MALDI-TOF-TOF. The use of the fluorescent ninhydrin assay to quantitatively detect free lysine hydrolyzed from peptides is the first application of its kind and serves as a paradigm for future studies. The visualization of peptide hydrolysis was accomplished by Tricine gel electrophoresis. Proteolytic processing of kinins alters their affinities toward specific cellular receptors and initiates signal transduction mechanisms responsible for inflammation, vasodilation, and enhanced vascular permeability. By applying novel approaches to determine the proteolytic potential of bacterial enzymes, we demonstrate that PGI-LysAP has broad exopeptidase activity which may enhance V. vulnificus invasiveness by altering peptides involved in signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513735      PMCID: PMC1428149          DOI: 10.1128/JB.188.6.2056-2062.2006

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  36 in total

Review 1.  Microbial proteinases as an universal trigger of kinin generation in microbial infections.

Authors:  H Maeda; K Maruo; T Akaike; H Kaminishi; Y Hagiwara
Journal:  Agents Actions Suppl       Date:  1992

Review 2.  Bioregulation of kinins: kallikreins, kininogens, and kininases.

Authors:  K D Bhoola; C D Figueroa; K Worthy
Journal:  Pharmacol Rev       Date:  1992-03       Impact factor: 25.468

Review 3.  Kallikrein-kinin in infection and cancer.

Authors:  H Maeda; J Wu; T Okamoto; K Maruo; T Akaike
Journal:  Immunopharmacology       Date:  1999-09

Review 4.  Vasoactive peptides in the skin.

Authors:  J Wallengren
Journal:  J Investig Dermatol Symp Proc       Date:  1997-08

Review 5.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

Review 6.  Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma.

Authors:  L Debeljuk; M Lasaga
Journal:  Peptides       Date:  1999       Impact factor: 3.750

7.  Tachykinin receptor modulators: novel therapeutics for rheumatoid arthritis.

Authors: 
Journal:  Expert Opin Investig Drugs       Date:  1999-11       Impact factor: 6.206

Review 8.  Pathogenesis of Vibrio vulnificus.

Authors:  D A Linkous; J D Oliver
Journal:  FEMS Microbiol Lett       Date:  1999-05-15       Impact factor: 2.742

9.  Metalloprotease is not essential for Vibrio vulnificus virulence in mice.

Authors:  C P Shao; L I Hor
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 10.  Neurokinin A. A pharmacological study.

Authors:  D Regoli; N E Rhaleb; S Dion; C Tousignant; N Rouissi; D Jukic; G Drapeau
Journal:  Pharmacol Res       Date:  1990 Jan-Feb       Impact factor: 7.658

View more
  1 in total

1.  Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice.

Authors:  Xiao-Fei Liu; Jing Wu; Ming-Yi Wang; Ying-Jian Chen; Yuan Cao; Cheng-Jin Hu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.